SEARCH

SEARCH BY CITATION

References

  • Acker T, Beck H, Plate KH (2001). Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization. Mech Dev 108: 4557.
  • Alonso De Diego SA, Gutierrez-Rodriguez M, Perez de Vega MJ, Gonzalez-Muniz R, Herranz R, Martin-Martinez M et al. (2006). The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity. Bioorg Med Chem Lett 16: 33963400.
  • Baker AM, Batchelor DC, Thomas GB, Wen JY, Rafiee M, Lin H et al. (2005). Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat. Neuropeptides 39: 8187.
  • Barbosa ES, Limongi JCP, Cummings JL (1997). Parkinson's disease. Neuropsych Basal Ganglia 20: 769790.
  • Batchelor DC, Lin H, Wen J-Y, Keven C, Van Zijl PL, Breier BH et al. (2003). Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats. Anal Biochem 323: 156163.
  • Beilharz EJ, Bassett NS, Sirimanne ES, Williams CE, Gluckman PD (1995). Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol Brain Res 29: 8191.
  • Betz AL, Keep RF, Beer ME, Ren XD (1994). Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab. 14: 2937.
  • Bickerdike MJ, Thomas GB, Batchelor DC, Sirimanne ES, Leong W, Lin H et al. (2009). NNZ-2566: A Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. J Neurol Sci 278: 890.
  • Blomgren K (2007). Pathological apoptosis in the developing brain. Apoptosis 12: 9931010.
  • Bourguignon JP, Gerard A (1999). Role of insulin-like growth factor binding proteins in limitation of IGF-1 degradation into the N-methyl-D-aspartate receptor antagonist GPE: evidence from gonadotrophin-releasing hormone secretion in vitro at two developmental stages. Brain Res 847: 247252.
  • Bourguignon JP, Gerard A, Alvarez Gonzalez ML, Franchimont P (1993). Acute suppression of gonadotropin-releasing hormone secretion by insulin-like growth factor I and subproducts: an age-dependent endocrine effect. Neuroendocrinology 58: 525530.
  • Brault S, Martinez-Bermudez AK, Marrache AM, Gobeil F Jr, Hou X, Beauchamp M et al. (2003). Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury. Stroke 34: 776782.
  • Byrnes KR, Faden AI (2007). Role of cell cycle proteins in CNS injury. Neurochem Res 32: 17991807.
  • Cao Y, Gunn AJ, Bennet L, Wu D, George S, Gluckman PD et al. (2003). Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab 23: 739747.
  • Coimbra C, Drake M, Boris-Moller F, Wieloch T (1996). Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes following ischemia. Stroke 27: 15781585.
  • Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1: 112119.
  • Dirnagl U, Iadecola C, Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391397.
  • Endrenyi L (1998). Drug distribution. In: KalantH, RoschlauWHE (eds). Principles of Medical Pharmacology, 6th edn. Oxford Univrsity Press: New York, pp. 2837.
  • Faden AI, Fox GB, Fan L, Araldi GL, Qiao L, Wang S et al. (1989). TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res 486: 228235.
  • Faden AI, Fox GB, Fan L, Araldi GL, Qiao L, Wang S et al. (1999). Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents. Am J Physiol 277: R1196R1204.
  • Faden AI, Knoblach SM, Cernak I, Fan L, Vink R, Araldi GL et al. (2003). Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J Cereb Blood Flow Metab 23: 342354.
  • Faden AI, Movsesyan VA, Knoblach SM, Ahmed F, Cernak I (2005). Neuroprotective effects of novel small peptides in vitro and after brain injury. Neuropharmacology 49: 410424.
  • Fisher M, Schaebitz W (2000). An overview of acute stroke therapy. Arch Intern Med 160: 31963206.
  • Frontczak-Baniewicz M, Walski M (2002). Non-sprouting angiogenesis in neurohypophysis after traumatic injury of the cerebral cortex. Electron-microscopic studies. Neuro Endocrinol Lett 23: 396404.
  • Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH (1999). Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842: 92100.
  • Ginsberg MD, Busto R (1989). Rodent models of cerebral ischemia. Stroke 20: 16271642.
  • Gladsrone DJ, Black SE, Hakim AM (2002). Toward wisdom from failure- Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33: 21232136.
  • Gluckman PD, Ambler GR (1992). Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies. Acta Paediatr Suppl 383: 134136.
  • Guan J, Williams C, Gunning M, Mallard C, Gluckman P (1993). The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb Blood Flow Metab 13: 609616.
  • Guan J, Williams CE, Skinner SJ, Mallard EC, Gluckman PD (1996). The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 137: 893898.
  • Guan J, Waldvogel HJ, Faull RL, Gluckman PD, Williams CE (1999). The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience 89: 649659.
  • Guan J, Beilharz EJ, Skinner SJ, Williams CE, Gluckman PD (2000a). Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemic brain injury. Brain Res 853: 163173.
  • Guan J, Gunn AJ, Sirimanne ES, Tuffin J, Gunning MI, Clark R et al. (2000b). The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery. J Cereb Blood Flow Metab 20: 513519.
  • Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P (2000c). N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 859: 286292.
  • Guan J, Bennet L, George S, Wu D, Waldvogel HJ, Gluckman PD et al. (2001a). Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab 21: 493502.
  • Guan J, Miller OT, Waugh KM, McCarthy D, Gluckman PD (2001b). Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Neuroscience 105: 299306.
  • Guan J, Thomas GB, Lin H, Mathai S, Bachelor DC, George S et al. (2004). Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats. Neuropharmacology 47: 892903.
  • Guan J, Mathai S, Harris AP, Wen JY, Zhang R, Brimble MA et al. (2007). Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats. Neuropharmacology 53: 749762.
  • Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H (2007). Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 27: 928938.
  • Harris PWR, Brimble MA, Muir VJ, Lai M, Trotter NS, Callis DJ (2005). Synthesis of proline-medified analogues of the neuroprotective agent glucyl-l-prolyl-glutamic acid (GPE). Tetrahedorn 61: 1001810035.
  • Hsu M, Sik A, Gallyas F, Horvath Z, Buzsaki G (1994). Short-term and long-term changes in the postischemic hippocampus. Ann NY Acad Sci 743: 121139.
  • Ikeda T, Waldbillig RJ, Puro DG (1995). Truncation of IGF-I yields two mitogens for retinal Muller glial cells. Brain Res 686: 8792.
  • Johnston BM, Mallard EC, Williams CE, Gluckman PD (1996). Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 97: 300308.
  • Kawaguchi Y (1997). Neostriatal cell subtypes and their functional roles. Neurosci Res 27: 18.
  • Kraig RP, Lascola CD, Cagiano A (1995). Glial response to brain ischemia. In: KettenmannH, RansomBR (eds). Neuroglia. Oxford University Press: New York, pp. 964976.
  • Krishnamurthi R, Stott S, Maingay M, Faull RL, McCarthy D, Gluckman P et al. (2004). N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport 15: 16011604.
  • Lee WH, Michels KM, Bondy CA (1993). Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II. Neuroscience 53: 251265.
  • Lee WH, Wang GM, Seaman LB, Vannucci SJ (1996). Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab 16: 227236.
  • Lees KR (2002). Management of acute stroke. Lancet Neurol 1: 4150.
  • Liu XF, Fawcett JR, Thorne RG, Frey WH 2nd (2001). Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett 308: 9194.
  • Lopez-Lopez C, LeRoith D, Torres-Aleman I (2004). Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA 101: 98339838.
  • Maragakis NJ, Rothstein JD (2006). Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2: 679689.
  • McNeill H, Williams C, Guan J, Dragunow M, Lawlor P, Sirimanne E et al. (1994). Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport 5: 901904.
  • Nilsson-Hakansson L, Civalero I, Zhang X, Carlsson-Skwirut C, Sara VR, Nordberg A (1993). Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain. Neuroreport 4: 11111114.
  • Olsson M, Nikkhah G, Bentlage C, Bjorklund A (1995). Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15: 38633875.
  • Panickar KS, Norenberg MD (2005). Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50: 287298.
  • Pardridge WM (2005). The blood-brain barrier: bottleneck in brain drug development. Neurorx 2: 314.
  • Pardridge WM (1991). Transnasal and intraventricular delivery of drugs. In: PardridgeWM (ed.). Peptide Drug Delivery to the Brain. Raven Press: New York, pp. 99122.
  • Pardridge WM (1997). Drug delivery to the brain. J Cereb Blood Flow Metab. 17: 713731.
  • Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006). Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1: 223236.
  • Planas AM, Sole S, Justicia C (2001). Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 8: 834846.
  • Preston E, Sutherland G, Finsten A (1993). Three openings of the blood-train barrier produced by forebrain ischemia in the rat. Neurosci Lett 149: 7578.
  • Ridet JL, Malhotra SK, Privat A, Gage FH (1997). Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570577.
  • Saatman KE, Contreras PC, Smith DH, Raghupathi R, McDermott KL, Fernandez SC et al. (1997). Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury. Exp Neurol 147: 418427.
  • Salhia B, Angelov L, Roncari L, Wu X, Shannon P, Guha A (2000). Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res 883: 8797.
  • Samonina G, Ashmarin I, Lyapina L (2002). Glyproline peptide family: review on bioactivity and possible origins. Pathophysiology 8: 229234.
  • Sara VR, Carlsson-Sdwirut C, Bergman T, Jornvall H, Roberts PJ, Crawford M et al. (1989). Indentification of Gly-Pre-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroaction peptide. Bioch Bioph Res Com 165: 766771.
  • Saura J, Curatolo L, Williams CE, Gatti S, Benatti L, Peeters C et al. (1999). Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro. Neuroreport 10: 161164.
  • Schwarting RK, Huston JP (1996). The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog in Neurobio 50: 275331.
  • Sizonenko SV, Sirimanne ES, Gluckman PD, Williams CE (2001). Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury. Brain Res 922: 4250.
  • Svedin P, Guan J, Mathai S, Zhang R, Wang X, Gustavsson M et al. (2007). Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat. Develop Neurosci 29: 393402.
  • Takami K, Hashimoto T, Shino A, Fukuda N (1991). Effect of thyrotropin-releasing hormone (TRH) in experimental spinal cord injury: a quantitative histopathologic study. Jpn J Pharmacol 57: 405417.
  • Tan WK, Williams CE, During MJ, Mallard CE, Gunning MI, Gunn AJ et al. (1996). Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr Res 39: 791797.
  • Tanaka K, Fukuuchi Y, Gomi S, Mihara B, Shirai T, Nogawa S et al. (1993). Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat. Neuroreport 4: 267270.
  • Yamaguchi F, Itano T, Miyamoto O, Janjua NA, Ohmoto T, Hosokawa K et al. (1991). Increase of extracellular insulin-like growth factor I (IGF-I) concentration following electrolytical lesion in rat hippocampus. Neurosci Lett 128: 273276.
  • Yamamoto H, Murphy LJ (1995a). Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: a further potential site of growth hormone regulation of IGF-I action. J Endocrinol 146: 141148.
  • Yamamoto H, Murphy LJ (1995b). N-terminal truncated insulin-like growth factor-I in human urine. J Clin Endocrinol Metab 80: 11791183.
  • Yamamoto H, Maake C, Murphy LJ (1999). Enhanced proteolytic activity directed against the N-terminal of IGF-I in diabetic rats. J Endocrinol 162: 243250.
  • Yuan J, Lipinski M, Degterev A (2003). Diversity in the mechanisms of neuronal cell death. Neuron 40: 401413.
  • Zhao X, Liu SJ, Zhang J, Strong R, Aronowski J, Grotta JC (2005). Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke 36: 129134.